BR9811250A - Peptìdeos compreendendo uma epìtopo de célula t, especìfica para colágeno ii - Google Patents
Peptìdeos compreendendo uma epìtopo de célula t, especìfica para colágeno iiInfo
- Publication number
- BR9811250A BR9811250A BR9811250-3A BR9811250A BR9811250A BR 9811250 A BR9811250 A BR 9811250A BR 9811250 A BR9811250 A BR 9811250A BR 9811250 A BR9811250 A BR 9811250A
- Authority
- BR
- Brazil
- Prior art keywords
- amino acid
- residue
- gly
- peptides
- xaa
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 102000008186 Collagen Human genes 0.000 title abstract 2
- 108010035532 Collagen Proteins 0.000 title abstract 2
- 229920001436 collagen Polymers 0.000 title abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 3
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 229940024606 amino acid Drugs 0.000 abstract 2
- 235000001014 amino acid Nutrition 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 abstract 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 abstract 1
- 229960001230 asparagine Drugs 0.000 abstract 1
- 235000009582 asparagine Nutrition 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 abstract 1
- 238000013160 medical therapy Methods 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
<B>"PEPTìDIOS COMPREENDENDO UMA EPìTOPO DE CéLULA T, ESPECìFICA PARA COLáGENO II"<D> A invenção fornece um peptídio isolado compreendendo uma sequência de aminoácido de fórmula (I): A~ 1~ - Xaa - Gly - A~ 4~ - A~ 5~ - Gly - A~ 7~ - Xaa - Gly (I) em que; - A~ 1~ representa um resíduo aminoácido com uma cadeia lateral aromática ou alifática; - A~ 4~ representa um resíduo de asparagina ou arginina ou um resíduo aminoácido com uma cadeia lateral aromártica ou alifática; - A~ 5~ representa qualquer aminoácido de ocorrência natural; - A~ 7~ representa um aminoácido com um resíduo carregado negativamente; - Xaa representa qualquer resíduo aminoácido; e - Gly representa um resíduo do glicina; e o uso de tais peptídios em terapia médica, particularmente no tratamento de condições auto-imunes, tal como artrite reumatóide.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9700301A SE9700301D0 (sv) | 1997-01-31 | 1997-01-31 | New compound |
| PCT/SE1998/000128 WO1998033811A1 (en) | 1997-01-31 | 1998-01-29 | Peptides comprising a t-cell epitope specific to collagen ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9811250A true BR9811250A (pt) | 2000-09-26 |
Family
ID=20405590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9811250-3A BR9811250A (pt) | 1997-01-31 | 1998-01-29 | Peptìdeos compreendendo uma epìtopo de célula t, especìfica para colágeno ii |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1007547A1 (pt) |
| JP (1) | JP2001511143A (pt) |
| KR (1) | KR20000070542A (pt) |
| CN (1) | CN1246125A (pt) |
| AU (1) | AU744907B2 (pt) |
| BR (1) | BR9811250A (pt) |
| CA (1) | CA2278638A1 (pt) |
| EE (1) | EE9900334A (pt) |
| HU (1) | HUP0000836A3 (pt) |
| ID (1) | ID22802A (pt) |
| IL (1) | IL131045A0 (pt) |
| IS (1) | IS5138A (pt) |
| NO (1) | NO993684L (pt) |
| NZ (1) | NZ336745A (pt) |
| PL (1) | PL334877A1 (pt) |
| SE (1) | SE9700301D0 (pt) |
| SK (1) | SK102199A3 (pt) |
| TR (1) | TR199901831T2 (pt) |
| WO (1) | WO1998033811A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO571297A0 (en) * | 1997-03-19 | 1997-04-10 | Montech Medical Developments Pty Ltd | Method for the diagnosis of rheumatoid arthritis |
| US7148020B2 (en) | 2001-07-12 | 2006-12-12 | Arexis Ab | Triple polypeptide complexes |
| CN1169829C (zh) * | 2002-06-27 | 2004-10-06 | 北京大学人民医院 | 非t细胞结合肽及其用途 |
| WO2008130217A1 (en) * | 2006-08-08 | 2008-10-30 | Applied Nanosystems B.V. | Cyclic angiotensin analogs |
| KR20170002734U (ko) | 2016-01-21 | 2017-07-31 | 김인수 | 자동 목재절단 장치 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08151396A (ja) * | 1994-11-28 | 1996-06-11 | Teijin Ltd | Ｈｌａ結合性オリゴペプチド及びそれを含有する免疫調節剤 |
| AU4695296A (en) * | 1995-01-06 | 1996-07-24 | Immulogic Pharmaceutical Corporation | Compositions and methods for treating rheumatoid arthritis |
-
1997
- 1997-01-31 SE SE9700301A patent/SE9700301D0/xx unknown
-
1998
- 1998-01-29 EP EP98902337A patent/EP1007547A1/en not_active Withdrawn
- 1998-01-29 WO PCT/SE1998/000128 patent/WO1998033811A1/en not_active Application Discontinuation
- 1998-01-29 CA CA002278638A patent/CA2278638A1/en not_active Abandoned
- 1998-01-29 CN CN98802141A patent/CN1246125A/zh active Pending
- 1998-01-29 KR KR1019997006787A patent/KR20000070542A/ko not_active Application Discontinuation
- 1998-01-29 JP JP53278598A patent/JP2001511143A/ja active Pending
- 1998-01-29 IL IL13104598A patent/IL131045A0/xx unknown
- 1998-01-29 ID IDW990738A patent/ID22802A/id unknown
- 1998-01-29 HU HU0000836A patent/HUP0000836A3/hu unknown
- 1998-01-29 AU AU58892/98A patent/AU744907B2/en not_active Ceased
- 1998-01-29 SK SK1021-99A patent/SK102199A3/sk unknown
- 1998-01-29 TR TR1999/01831T patent/TR199901831T2/xx unknown
- 1998-01-29 PL PL98334877A patent/PL334877A1/xx unknown
- 1998-01-29 BR BR9811250-3A patent/BR9811250A/pt not_active IP Right Cessation
- 1998-01-29 EE EEP199900334A patent/EE9900334A/xx unknown
- 1998-01-29 NZ NZ336745A patent/NZ336745A/en unknown
-
1999
- 1999-07-28 IS IS5138A patent/IS5138A/is unknown
- 1999-07-29 NO NO993684A patent/NO993684L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2278638A1 (en) | 1998-08-06 |
| IL131045A0 (en) | 2001-01-28 |
| AU5889298A (en) | 1998-08-25 |
| WO1998033811A1 (en) | 1998-08-06 |
| EE9900334A (et) | 2000-02-15 |
| ID22802A (id) | 1999-12-09 |
| HUP0000836A2 (hu) | 2000-11-28 |
| EP1007547A1 (en) | 2000-06-14 |
| NZ336745A (en) | 2001-09-28 |
| KR20000070542A (ko) | 2000-11-25 |
| IS5138A (is) | 1999-07-28 |
| AU744907B2 (en) | 2002-03-07 |
| CN1246125A (zh) | 2000-03-01 |
| HUP0000836A3 (en) | 2001-04-28 |
| NO993684L (no) | 1999-09-02 |
| NO993684D0 (no) | 1999-07-29 |
| JP2001511143A (ja) | 2001-08-07 |
| SK102199A3 (en) | 2000-08-14 |
| SE9700301D0 (sv) | 1997-01-31 |
| PL334877A1 (en) | 2000-03-27 |
| TR199901831T2 (xx) | 1999-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU896391D0 (en) | Peptides with medicative effect | |
| MX9902661A (en) | High level expression of proteins | |
| HUP0204199A2 (hu) | Transzport vektorok | |
| DE69535147D1 (de) | Überexpression von säugetier- und virusproteinen | |
| NZ263344A (en) | Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use | |
| DE69841105D1 (de) | Chemokine peptide, varianten, derivate und analoge. ihre verwendung in methode für die hemmung oder erhöhung von einer entzündungsreaktion | |
| DK0643726T3 (da) | Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei | |
| BR9713108A (pt) | Colagenase recombinante do tipo i de clostridium histolytucum e o uso da mesma para o isolamento de células e de grupos de células | |
| ATE177757T1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
| TW364850B (en) | Nematocidal compositions | |
| NO970282D0 (no) | Adénovirus omfattende et gen som koder for glutationperoksydase | |
| UA32523C2 (uk) | Пептиди, які мають високу біологічну активність, та фармацевтична композиція на їх основі | |
| AR002742A1 (es) | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn | |
| BR9811250A (pt) | Peptìdeos compreendendo uma epìtopo de célula t, especìfica para colágeno ii | |
| DK0687270T3 (da) | Osteogene vækstoligopeptider og farmaceutiske præparater indeholdende disse | |
| DE69935414D1 (en) | Humanes btrcp protein | |
| ES8801317A1 (es) | Un procedimiento para preparar un material peptidico que tiene actividad humoral timica | |
| EP0917535A4 (en) | NEURO-ACTIVE PEPTIDE | |
| AR026068A1 (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia. | |
| BR9608626A (pt) | Peptédeo preparação farmacéutica e uso de um peptídeo | |
| ATE452903T1 (de) | Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten | |
| TR200100175T2 (tr) | Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler. | |
| BG103859A (en) | The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions | |
| ATE174927T1 (de) | Haemoregulatorische penta-oder hexapeptide | |
| AU1971899A (en) | Use of citrulline peptides derived from filaggrin for treating autoimmune diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A, 8A E 9A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007. |